Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Helen Ke"'
Autor:
Huaikai Shi, Le Zhang, Ta-Kun Yu, Ling Zhuang, Helen Ke, Ben Johnson, Emma Rath, Kenneth Lee, Sonja Klebe, Steven Kao, Karl Lijun Qin, Hong Ngoc Thuy Pham, Quan Vuong, Yuen Yee Cheng
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Pleural mesothelioma (PM) is a highly aggressive, fast-growing asbestos-induced cancer with limited effective treatments. There has been interest in using naturally occurring anticancer agents derived from plant materials for the treatment of PM. How
Externí odkaz:
https://doaj.org/article/f7bda3470b64469a857813ac0952bd5d
Autor:
Huaikai Shi, Emma M. Rath, Ruby C. Y. Lin, Kadir Harun Sarun, Candice Julie Clarke, Brian C. McCaughan, Helen Ke, Anthony Linton, Kenneth Lee, Sonja Klebe, Joanneke Maitz, Kedong Song, Yiwei Wang, Steven Kao, Yuen Yee Cheng
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Traditional studies using cancer cell lines are often performed on a two-dimensional (2D) cell culture model with a low success rate of translating to Phase I or Phase II clinical studies. In comparison, with the advent of developments three-dimensio
Externí odkaz:
https://doaj.org/article/6d90a4a69dd34c658dbc9f753d07dc28
Autor:
Helen Ke, MBBS (Hons), Anthony J. Gill, AM, MBBS, FRCPA, Catriona McKenzie, MBBS (Hons1), FRCPA, James G. Kench, MBBS, Bsc(Med), FRCPA, Renee C.F. Chan, MBBS(Hons1), FRCPA, Nick Pavlakis, BSc, MBBS, MMed(Clin. Epi), PhD, FRACP, Michael Fulham, MBBS(Hons), FRACP, Cherry Koh, MBBS (Hons), MS, FRACS, Steven Kao, BHB, MBChB, PhD, FRACP
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100236- (2021)
Malignant mesothelioma with EWSR1-ATF1 fusion is a rare malignancy described in young adults without asbestos exposure. To the best of our knowledge, outcomes to local and systemic therapies for this subtype of malignant mesothelioma have not been de
Externí odkaz:
https://doaj.org/article/4276d0c706c24f83ba19a45b265d9305
Autor:
Huaikai Shi, Le Zhang, Ta-Kun Yu, Ling Zheng, Helen Ke, Ben Johnson, Emma Rath, Kenneth Lee, Sonja Klebe, Steven Kao, Karl Lijun Qin, Hong Ngoc Thuy Pham, Quan Vuong, Yuen Yee Cheng
Pleural mesothelioma (PM) is a highly aggressive, fast-growing asbestos-induced cancer with limited effective treatments. There has been an interest in using naturally occurring anticancer agents derived from plant materials for the treatment of PM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32a20f0d4a062a33e6e165a14582a95f
https://doi.org/10.1101/2022.12.06.519377
https://doi.org/10.1101/2022.12.06.519377
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 18:177-190
Malignant pleural mesothelioma (MPM) is an incurable malignancy associated with high symptom burden and poor prognosis. The relationship between asbestos exposure and MPM incidence is well-established. The incidence rate of MPM in Australia and New Z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1225db581d0aa4defeafe588bc1cc6
https://doi.org/10.1111/ajco.13611
https://doi.org/10.1111/ajco.13611
Autor:
Rebecca A Hyland, Agata Chrzanowska, Kirsty Hannaford‐Turner, Alexander Davis, Helen Ke, Lauren Bradbury, Adnan Nagrial, Brian McCaughan, Rina Hui, Nico van Zandwijk, Ken Takahashi, Steven C Kao
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 18
Due to difficulties in identifying sufficient-sized cohorts there remains uncertainty about prognostic and clinical differences that may be unique to asbestos-related lung cancer (ARLC). In this study, we use the Helsinki Criteria to define a group o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c094d4f2e5d1a92d54dd961e33895c9
https://doi.org/10.1111/ajco.13664
https://doi.org/10.1111/ajco.13664
Autor:
Renee C.F. Chan, Nick Pavlakis, Anthony J. Gill, James G. Kench, Michael J. Fulham, Helen Ke, Steven Kao, Catriona McKenzie, Cherry Koh
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100236-(2021)
JTO Clinical and Research Reports
JTO Clinical and Research Reports
Malignant mesothelioma with EWSR1-ATF1 fusion is a rare malignancy described in young adults without exposure to asbestos. To our knowledge, outcomes to local and systemic therapies for this subtype of malignant mesothelioma have not been described.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0499d9f0303721160b368b7ec94967
http://www.sciencedirect.com/science/article/pii/S2666364321000953
http://www.sciencedirect.com/science/article/pii/S2666364321000953
Publikováno v:
Lung Cancer (Auckland, N.Z.). 13
The treatment paradigm for malignant pleural mesothelioma (MPM) has changed little in the last 18 years. Radical intent treatment, consisting of surgical resection, radiotherapy and chemotherapy, has been offered to a highly select few; however, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81825112c13069be361c489f93ed77f2
https://pubmed.ncbi.nlm.nih.gov/35264891
https://pubmed.ncbi.nlm.nih.gov/35264891
Autor:
Robert D. Henderson, Kimberley Au, Susanna B. Park, David Goldstein, Julie Marker, Tiffany Li, Eva Battaglini, Helen Ke, Peter Geelan-Small, Peter Grimison, David Mizrahi, David Wyld, Brian Wall, Hannah C. Timmins, Terry Trinh
Publikováno v:
JAMA Network Open
Key Points Question Are pretreatment blood-based and clinical factors associated with chemotherapy-induced peripheral neuropathy (CIPN) persistence posttreatment in patients who have received paclitaxel or oxaliplatin? Findings In this cohort study o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e604a1904f235673410e4bd3af8fd8ef
https://doi.org/10.1001/jamanetworkopen.2020.36695
https://doi.org/10.1001/jamanetworkopen.2020.36695
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.